AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Control Bionics Ltd

0.060

0.000

Volume:704.80K

Turnover:42.28K

Market Cap:32.59M

PE:-2.90

High:0.061

Open:0.061

Low:0.059

Close:0.060

52wk High:0.095

52wk Low:0.032

Shares:543.09M

Float Shares:114.48M

Volume Ratio:0.49

T/O Rate:0.62%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.021

EPS(LYR):-0.023

ROE:-91.56%

ROA:-40.30%

PB:4.22

PE(LYR):-2.59

Loading ...

Overview Company News Filings

An Insider Of Control Bionics Picks Up 183% More Stock

Simply Wall St.

Australia's Control Bionics Jumps After FDA Listing for NeuroStrip Device

Control Bionics Completes US FDA Registration, Device Listing for Neurostrip

Control Bionics Ltd-US FDA Registration and Device Listing for Neurostrip

THOMSON REUTERS

CBL & Associates Properties (CBL) Could Be 21% Overvalued After Russell Index Removals

Simply Wall St.

Control Bionics Ltd-security Purchase Plan Offer Document

THOMSON REUTERS

CBL & Associates Properties (CBL) Drops From Russell Value Indices, Does It Look Fully Valued?

Simply Wall St.

BRIEF-Control Bionics Says Trading Halt

Control Bionics - Trading Halt Requested Pending Material Capital Raising Announcement

THOMSON REUTERS

Control Bionics Ltd-Commercial Momentum, Execution and Market Access Update

THOMSON REUTERS

We're Keeping An Eye On Control Bionics' (ASX:CBL) Cash Burn Rate

Simply Wall St.

Earnings Flash (CBL) CBL Properties Reports Q1 Adjusted FFO $1.73 a Share

MT Newswires Live

Control Bionics Ltd-Control Bionics Strategic Transition Presentation

THOMSON REUTERS

Will CBL & Associates Properties' (CBL) Higher Dividend Baseline Redefine Its Income Reliability Narrative?

Simply Wall St.

Why CBL & Associates Properties (CBL) Is Up 7.8% After Debt Refi And Dividend Hike - And What's Next

Simply Wall St.

How Investors Are Reacting To CBL & Associates Properties (CBL) Pushing Debt Maturities Out To 2031

Simply Wall St.

BRIEF-Control Bionics Announces First U.S. Letter Of Intent For Ios Speech Device Program

Control Bionics Ltd - Shipments Under Program Are Expected to Commence Towards End of FY26

THOMSON REUTERS

Control Bionics - Device Volume Once Delivered Is Expected to Generate Between US$2.5-3.5M Revenue Annually

THOMSON REUTERS

Control Bionics Ltd - U.S. Letter of Intent for iOS Speech Device Program

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/CBL.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CBL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CBL.AU\",,,,,undefined,":{"symbol":"CBL.AU","market":"AU","secType":"STK","nameCN":"Control Bionics Ltd","latestPrice":0.06,"timestamp":1787292720000,"preClose":0.06,"halted":0,"volume":704803,"delay":0,"changeRate":0,"nameEN":"Control Bionics Ltd","floatShares":114482928,"shares":543088709,"eps":-0.020704,"marketStatus":"Not Yet Opened","change":0,"latestTime":"08-21 16:12:00 AEST","open":0.061,"high":0.061,"low":0.059,"amount":42284,"amplitude":0.033333,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.020704,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787529600000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.06,"openAndCloseTimeList":[[1787270400000,1787292000000]],"volumeRatio":0.48634372243044893,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"CBL.AU","preClose":0.06,"auctionPrice":0.059,"auctionVolume":70000,"auction":3,"marketStatus":"盘后竞价","timestamp":1786687653137}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CBL.AU\",,,,,undefined,":{"symbol":"CBL.AU","floatShares":114482928,"roa":"-40.30%","roe":"-91.56%","lyrEps":-0.023131,"volumeRatio":0.48634372243044893,"shares":543088709,"dividePrice":0,"high":0.061,"amplitude":0.033333,"preClose":0.06,"low":0.059,"week52Low":0.032,"pbRate":"4.22","psRate":"5.37","week52High":0.095,"institutionHeld":0,"latestPrice":0.06,"eps":-0.020704,"divideRate":0,"volume":704803,"delay":0,"ttmEps":-0.020704,"open":0.061,"prevYearClose":0.061,"prevWeekClose":0.06,"prevMonthClose":0.064,"prevQuarterClose":0.074,"fiveDayClose":0.059,"twentyDayClose":0.069,"sixtyDayClose":0.055,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CBL.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2026-02-26","symbol":"CBL.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1772024400000,"reportTimeType":"","actualEps":null},{"market":"AU","date":"2025-09-01","symbol":"CBL.AU","defaultRemindTime":1756684800000,"type":"split","dateTimestamp":1756648800000,"forFactor":982905,"toFactor":1000000,"ratio":0.9829049999999999},{"date":"2025-07-31","symbol":"CBL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1753920000000,"name":null,"time":"","dateTimestamp":1753884000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CBL.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CBL.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659664185","title":"An Insider Of Control Bionics Picks Up 183% More Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2659664185","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659664185?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:02","pubTimestamp":1786564925,"startTime":"0","endTime":"0","summary":"Investors who take an interest in Control Bionics Limited ( ASX:CBL ) should definitely note that insider Stephen Rix...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-cbl/control-bionics-shares/news/an-insider-of-control-bionics-picks-up-183-more-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-cbl/control-bionics-shares/news/an-insider-of-control-bionics-picks-up-183-more-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CBL.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656583245","title":"Australia's Control Bionics Jumps After FDA Listing for NeuroStrip Device","url":"https://stock-news.laohu8.com/highlight/detail?id=2656583245","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656583245?lang=en_us&edition=fundamental","pubTime":"2026-08-04 08:43","pubTimestamp":1785804218,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Control Bionics jumps after FDA listing for NeuroStrip device** Shares of Australia's Control BionicsCBL.AXrise as much as 10.8% to A$0.072, posting their biggest intraday pct gain since June 5** Stock hits its highest level since July 16** Neurotechnology firm says its NeuroStrip surface EMG wearable platform has been registered and listed with the U.S. Food and Drug Administration  as a medical device** NeuroStrip offers insight into muscle activation and intent through bioelectric signals and spatial movements** CBL has also submitted applications for regulatory approval in additional key jurisdictions, including registration with the Therapeutic Goods Administration  in Australia, among others** Stock up nearly 15% this year, including the day's move","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL4N44101L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","CBL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656300902","title":"Control Bionics Completes US FDA Registration, Device Listing for Neurostrip","url":"https://stock-news.laohu8.com/highlight/detail?id=2656300902","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656300902?lang=en_us&edition=fundamental","pubTime":"2026-08-04 06:41","pubTimestamp":1785796903,"startTime":"0","endTime":"0","summary":"Aug 4 (Reuters) - Control Bionics Ltd::*US FDA REGISTRATION AND DEVICE LISTING FOR NEUROSTRIP*Further company coverage: CBL.AX* ((Reuters.Briefs@thomsonreuters.com;))((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))Source Date/Time = 03-AUG-202622:27:59 GMT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nRSD776kkg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","CBL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656300528","title":"Control Bionics Ltd-US FDA Registration and Device Listing for Neurostrip","url":"https://stock-news.laohu8.com/highlight/detail?id=2656300528","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656300528?lang=en_us&edition=fundamental","pubTime":"2026-08-04 06:26","pubTimestamp":1785796011,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nTUEBBMJYL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CBL.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650945967","title":"CBL & Associates Properties (CBL) Could Be 21% Overvalued After Russell Index Removals","url":"https://stock-news.laohu8.com/highlight/detail?id=2650945967","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650945967?lang=en_us&edition=fundamental","pubTime":"2026-07-09 12:54","pubTimestamp":1783572845,"startTime":"0","endTime":"0","summary":"CBL & Associates Properties (CBL) has just been dropped from several Russell Value indices, a broad index reset that can affect how index funds treat the stock and may help explain recent shifts in its market profile.\nSee our latest analysis for CBL & Associates Properties.\nSet against the Russell Value index removals, CBL & Associates Properties has seen mixed short term sentiment. The 1 day share price return is down 3.08% and the 7 day share price return is down 6.15%. However, the 30 day...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551736-choice2-main-header/1585186602415","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551736-choice2-main-header/1585186602415"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate/nyse-cbl/cbl-associates-properties/news/cbl-associates-properties-cbl-could-be-21-overvalued-after-r","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate/nyse-cbl/cbl-associates-properties/news/cbl-associates-properties-cbl-could-be-21-overvalued-after-r","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CBL.AU","BK4080","BK7007","CBL","DCF","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648520323","title":"Control Bionics Ltd-security Purchase Plan Offer Document","url":"https://stock-news.laohu8.com/highlight/detail?id=2648520323","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648520323?lang=en_us&edition=fundamental","pubTime":"2026-07-02 08:50","pubTimestamp":1782953403,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nTUE6SRBSZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","CBL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648042542","title":"CBL & Associates Properties (CBL) Drops From Russell Value Indices, Does It Look Fully Valued?","url":"https://stock-news.laohu8.com/highlight/detail?id=2648042542","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648042542?lang=en_us&edition=fundamental","pubTime":"2026-07-01 23:59","pubTimestamp":1782921564,"startTime":"0","endTime":"0","summary":"Index removals put CBL & Associates Properties in focus\nCBL & Associates Properties (CBL) has been removed from several Russell value indices, a mechanical shift that can prompt index-tracking funds to adjust positions and often brings the stock onto active investors' watchlists.\nSee our latest analysis for CBL & Associates Properties.\nDespite the index removals, CBL & Associates Properties has seen firm momentum recently, with a 7 day share price return of 5.99% and a 90 day share price...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551736-choice2-main-header/1585186602415","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551736-choice2-main-header/1585186602415"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate/nyse-cbl/cbl-associates-properties/news/cbl-associates-properties-cbl-drops-from-russell-value-indic","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate/nyse-cbl/cbl-associates-properties/news/cbl-associates-properties-cbl-drops-from-russell-value-indic","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4231","CBL.AU","DCF","BK7007","BK4080","CBL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645631168","title":"BRIEF-Control Bionics Says Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2645631168","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645631168?lang=en_us&edition=fundamental","pubTime":"2026-06-24 09:36","pubTimestamp":1782264990,"startTime":"0","endTime":"0","summary":"BRIEF-Control Bionics Says Trading HaltJune 24 (Reuters) - Control Bionics Ltd CBL.AX:TRADING HALT REQUESTED PENDING MATERIAL CAPITAL RAISING ANNOUNCEMENTFurther company coverage: CBL.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nFWN42V0ZF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBL.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645485064","title":"Control Bionics - Trading Halt Requested Pending Material Capital Raising Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=2645485064","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645485064?lang=en_us&edition=fundamental","pubTime":"2026-06-24 08:11","pubTimestamp":1782259883,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nFWN42V0ZF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CBL.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640875581","title":"Control Bionics Ltd-Commercial Momentum, Execution and Market Access Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2640875581","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640875581?lang=en_us&edition=fundamental","pubTime":"2026-06-04 06:25","pubTimestamp":1780525549,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUE2MZP5P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CBL.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634249345","title":"We're Keeping An Eye On Control Bionics' (ASX:CBL) Cash Burn Rate","url":"https://stock-news.laohu8.com/highlight/detail?id=2634249345","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634249345?lang=en_us&edition=fundamental","pubTime":"2026-05-09 04:32","pubTimestamp":1778272344,"startTime":"0","endTime":"0","summary":"Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-cbl/control-bionics-shares/news/were-keeping-an-eye-on-control-bionics-asxcbl-cash-burn-rate","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-cbl/control-bionics-shares/news/were-keeping-an-eye-on-control-bionics-asxcbl-cash-burn-rate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4080","BK4231","CBL.AU","BK7007","CBL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633552484","title":"Earnings Flash (CBL) CBL Properties Reports Q1 Adjusted FFO $1.73 a Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2633552484","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633552484?lang=en_us&edition=fundamental","pubTime":"2026-05-08 20:06","pubTimestamp":1778241981,"startTime":"0","endTime":"0","summary":"Earnings Flash (CBL) CBL Properties Reports Q1 Adjusted FFO $1.73 a Share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CBL","CBL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633479964","title":"Control Bionics Ltd-Control Bionics Strategic Transition Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2633479964","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633479964?lang=en_us&edition=fundamental","pubTime":"2026-05-05 06:11","pubTimestamp":1777932671,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nTUE1MRRPN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CBL.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627455893","title":"Will CBL & Associates Properties' (CBL) Higher Dividend Baseline Redefine Its Income Reliability Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2627455893","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627455893?lang=en_us&edition=fundamental","pubTime":"2026-04-13 20:14","pubTimestamp":1776082444,"startTime":"0","endTime":"0","summary":"CBL & Associates Properties recently boosted its first-quarter 2026 payout by approving a special US$0.175 per-share cash dividend, lifting the total quarterly dividend to US$0.625 and implying an annualized rate of US$2.50 per common share, subject to ongoing Board approval.\nThis move effectively raises the company’s regular dividend baseline, signaling a stronger commitment to returning cash to shareholders and potentially reshaping how investors view the reliability of its income...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551736-choice2-main-header/1585186602415","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551736-choice2-main-header/1585186602415"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate/nyse-cbl/cbl-associates-properties/news/will-cbl-associates-properties-cbl-higher-dividend-baseline","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate/nyse-cbl/cbl-associates-properties/news/will-cbl-associates-properties-cbl-higher-dividend-baseline","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CBL.AU","CBL","BK4588","BK4231","VIG","BK7007","BK4585","BK4080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625207876","title":"Why CBL & Associates Properties (CBL) Is Up 7.8% After Debt Refi And Dividend Hike - And What's Next","url":"https://stock-news.laohu8.com/highlight/detail?id=2625207876","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625207876?lang=en_us&edition=fundamental","pubTime":"2026-04-06 14:11","pubTimestamp":1775455912,"startTime":"0","endTime":"0","summary":"In late March and early April 2026, CBL & Associates Properties closed more than US$219 million of new non-recourse loans and announced a higher first-quarter dividend of US$0.625 per share, lifting its annualized common dividend rate to US$2.50.\nThese financings extend key debt maturities, boost estimated annual free cash flow by over US$30 million, and support a larger, potentially ongoing dividend payout alongside a cash balance above US$291 million.\nWe’ll now examine how the extended...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551736-choice2-main-header/1585186602415","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551736-choice2-main-header/1585186602415"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate/nyse-cbl/cbl-associates-properties/news/why-cbl-associates-properties-cbl-is-up-78-after-debt-refi-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate/nyse-cbl/cbl-associates-properties/news/why-cbl-associates-properties-cbl-is-up-78-after-debt-refi-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["VIG","CBL.AU","BK4588","BK7007","BK4080","CBL","BK4231","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623360120","title":"How Investors Are Reacting To CBL & Associates Properties (CBL) Pushing Debt Maturities Out To 2031","url":"https://stock-news.laohu8.com/highlight/detail?id=2623360120","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623360120?lang=en_us&edition=fundamental","pubTime":"2026-03-30 10:05","pubTimestamp":1774836308,"startTime":"0","endTime":"0","summary":"CBL & Associates Properties, Inc. recently closed a US$176 million floating-rate, non-recourse loan with Beal Bank USA, secured mainly by three lifestyle and open-air centers, as the final step in refinancing its former US$634 million secured term loan.\nThe combined refinancings push the secured debt maturity out to 2031, trim total debt by more than US$33 million, and are expected to improve annual free cash flow by over US$30 million while leaving CBL with an estimated cash balance above...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551736-choice2-main-header/1585186602415","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551736-choice2-main-header/1585186602415"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate/nyse-cbl/cbl-associates-properties/news/how-investors-are-reacting-to-cbl-associates-properties-cbl-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate/nyse-cbl/cbl-associates-properties/news/how-investors-are-reacting-to-cbl-associates-properties-cbl-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7007","BK4211","BK4585","BK4080","BK4543","AGIX","ISBC","CBL.AU","CHAT","BK4588","AIPO","AI","BK4231","BK4528","AIYY","BK4551","BK4587","BK4023","CBL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622347889","title":"BRIEF-Control Bionics Announces First U.S. Letter Of Intent For Ios Speech Device Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2622347889","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622347889?lang=en_us&edition=fundamental","pubTime":"2026-03-26 08:59","pubTimestamp":1774486763,"startTime":"0","endTime":"0","summary":"BRIEF-Control Bionics Announces First U.S. Letter Of Intent For Ios Speech Device ProgramMarch 26  - Control Bionics Ltd CBL.AX:FIRST U.S. LETTER OF INTENT FOR IOS SPEECH DEVICE PROGRAMU.S. LETTER OF INTENT FOR IOS SPEECH DEVICE PROGRAMSHIPMENTS UNDER PROGRAM ARE EXPECTED TO COMMENCE TOWARDS END OF FY26LOI OUTLINES CUSTOMER'S INTENTION TO BUY SIGNIFICANT NUMBER OF IOS- BASED SPEECH GENERATING DEVICES ANNUALLYDEVICE VOLUME ONCE DELIVERED IS EXPECTED TO GENERATE BETWEEN US$2.5-3.5M REVENUE ANNUALLYFurther company coverage: CBL.AX ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nFWN40D11V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","CBL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622764007","title":"Control Bionics Ltd -  Shipments Under Program Are Expected to Commence Towards End of FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2622764007","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622764007?lang=en_us&edition=fundamental","pubTime":"2026-03-26 05:21","pubTimestamp":1774473704,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nFWN40D11V:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","CBL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622200776","title":"Control Bionics - Device Volume Once Delivered Is Expected to Generate Between US$2.5-3.5M Revenue Annually","url":"https://stock-news.laohu8.com/highlight/detail?id=2622200776","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622200776?lang=en_us&edition=fundamental","pubTime":"2026-03-26 05:21","pubTimestamp":1774473704,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nFWN40D11V:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CBL.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622007785","title":"Control Bionics Ltd - U.S. Letter of Intent for iOS Speech Device Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2622007785","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622007785?lang=en_us&edition=fundamental","pubTime":"2026-03-26 05:21","pubTimestamp":1774473704,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nFWN40D11V:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CBL.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":25,"code":"91000000","status":"200"}]}}